[Recombinant hepatitis B vaccine in health personnel of the Peruvian Institute of Social Security].
The immune response to cuban recombinant Hepatitis B vaccine was studied (sero conversion, sero protection, hyper response and geometric median) in 211 health workers from different general hospitals of Peruvian Social Security, along the coast of Perú. Vaccine was given by deltoid intramuscular injection at 0-1-2 months interval. Quantification of Anti HBS was done according to Organon Tecknica Methodology. Sero protection was obtained in 97% of people studied just at days of the first injection. Women less than 40 years old showed better immunogenic response. This Hepatitis B Vaccine program is recommended due to its symmetry, short time course and high immune protection obtained.
Zumaeta
E
E
Servicio de Gastroenterología Hospital E. Rebagliati M., Lima.
Figueroa
R
R
Ferrándiz
J
J
González Griego
A
A
Ramírez Albajés
V
V
D000328:Adult; D000367:Age Factors; D005260:Female; D006282:Health Personnel; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D008297:Male; D010568:Peru; D012737:Sex Factors; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic
Vacuna recombinante contra la hepatitis viral B en trabajadores de la salud del Instituto Peruano de la Seguridad Social.